Logo image of PNOR.OL

PETRONOR E&P ASA (PNOR.OL) Stock Fundamental Analysis

OSL:PNOR - Euronext Oslo - NO0012942525 - Common Stock - Currency: NOK

11.3  +0.18 (+1.62%)

Fundamental Rating

7

Overall PNOR gets a fundamental rating of 7 out of 10. We evaluated PNOR against 61 industry peers in the Oil, Gas & Consumable Fuels industry. PNOR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PNOR is valued quite cheap, but it does not seem to be growing. These ratings would make PNOR suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PNOR was profitable.
In the past year PNOR had a positive cash flow from operations.
PNOR had positive earnings in each of the past 5 years.
Of the past 5 years PNOR 4 years had a positive operating cash flow.
PNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFPNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

PNOR's Return On Assets of 8.81% is fine compared to the rest of the industry. PNOR outperforms 78.69% of its industry peers.
The Return On Equity of PNOR (13.53%) is comparable to the rest of the industry.
PNOR has a Return On Invested Capital of 17.63%. This is amongst the best in the industry. PNOR outperforms 88.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PNOR is significantly above the industry average of 15.03%.
The 3 year average ROIC (25.97%) for PNOR is well above the current ROIC(17.63%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.81%
ROE 13.53%
ROIC 17.63%
ROA(3y)18.05%
ROA(5y)13.4%
ROE(3y)28.54%
ROE(5y)27.26%
ROIC(3y)25.97%
ROIC(5y)29.21%
PNOR.OL Yearly ROA, ROE, ROICPNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

With a decent Profit Margin value of 13.40%, PNOR is doing good in the industry, outperforming 67.21% of the companies in the same industry.
PNOR's Profit Margin has improved in the last couple of years.
PNOR has a better Operating Margin (41.83%) than 90.16% of its industry peers.
In the last couple of years the Operating Margin of PNOR has remained more or less at the same level.
The Gross Margin of PNOR (49.30%) is comparable to the rest of the industry.
PNOR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 41.83%
PM (TTM) 13.4%
GM 49.3%
OM growth 3Y-9.51%
OM growth 5Y-1.13%
PM growth 3Y12.45%
PM growth 5YN/A
GM growth 3Y-10.4%
GM growth 5Y-5.31%
PNOR.OL Yearly Profit, Operating, Gross MarginsPNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

10

2. Health

2.1 Basic Checks

PNOR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
PNOR has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for PNOR has been reduced compared to 5 years ago.
PNOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PNOR.OL Yearly Shares OutstandingPNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PNOR.OL Yearly Total Debt VS Total AssetsPNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.69 indicates that PNOR is not in any danger for bankruptcy at the moment.
PNOR has a Altman-Z score of 3.69. This is amongst the best in the industry. PNOR outperforms 80.33% of its industry peers.
PNOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.69
ROIC/WACC2.04
WACC8.65%
PNOR.OL Yearly LT Debt VS Equity VS FCFPNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

PNOR has a Current Ratio of 3.97. This indicates that PNOR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.97, PNOR belongs to the top of the industry, outperforming 91.80% of the companies in the same industry.
PNOR has a Quick Ratio of 3.53. This indicates that PNOR is financially healthy and has no problem in meeting its short term obligations.
PNOR has a Quick ratio of 3.53. This is amongst the best in the industry. PNOR outperforms 90.16% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.53
PNOR.OL Yearly Current Assets VS Current LiabilitesPNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

PNOR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -75.12%.
Measured over the past years, PNOR shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.60% on average per year.
The Revenue for PNOR has decreased by -49.41% in the past year. This is quite bad
PNOR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.76% yearly.
EPS 1Y (TTM)-75.12%
EPS 3Y38.6%
EPS 5YN/A
EPS Q2Q%-88.74%
Revenue 1Y (TTM)-49.41%
Revenue growth 3Y24.31%
Revenue growth 5Y14.76%
Sales Q2Q%-68.56%

3.2 Future

Based on estimates for the next years, PNOR will show a very negative growth in Earnings Per Share. The EPS will decrease by -41.61% on average per year.
PNOR is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.47% yearly.
EPS Next Y-25%
EPS Next 2Y-41.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.06%
Revenue Next 2Y-20.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PNOR.OL Yearly Revenue VS EstimatesPNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
PNOR.OL Yearly EPS VS EstimatesPNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

PNOR is valuated cheaply with a Price/Earnings ratio of 6.38.
Compared to the rest of the industry, the Price/Earnings ratio of PNOR indicates a rather cheap valuation: PNOR is cheaper than 83.61% of the companies listed in the same industry.
PNOR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
Based on the Price/Forward Earnings ratio of 7.29, the valuation of PNOR can be described as very cheap.
Based on the Price/Forward Earnings ratio, PNOR is valued a bit cheaper than the industry average as 78.69% of the companies are valued more expensively.
PNOR is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.38
Fwd PE 7.29
PNOR.OL Price Earnings VS Forward Price EarningsPNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PNOR is valued cheaply inside the industry as 98.36% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PNOR indicates a rather cheap valuation: PNOR is cheaper than 90.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.36
EV/EBITDA 0.55
PNOR.OL Per share dataPNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of PNOR may justify a higher PE ratio.
PNOR's earnings are expected to decrease with -41.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PNOR!.
Industry RankSector Rank
Dividend Yield N/A

PETRONOR E&P ASA

OSL:PNOR (7/11/2025, 7:00:00 PM)

11.3

+0.18 (+1.62%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-20 2025-05-20
Earnings (Next)08-20 2025-08-20
Inst Owners0.9%
Inst Owner ChangeN/A
Ins Owners2.25%
Ins Owner ChangeN/A
Market Cap1.61B
Analysts82.86
Price Target13.26 (17.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.38
Fwd PE 7.29
P/S 0.91
P/FCF 3.36
P/OCF 2.61
P/B 0.92
P/tB 0.97
EV/EBITDA 0.55
EPS(TTM)1.77
EY15.66%
EPS(NY)1.55
Fwd EY13.71%
FCF(TTM)3.36
FCFY29.73%
OCF(TTM)4.32
OCFY38.24%
SpS12.39
BVpS12.26
TBVpS11.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.81%
ROE 13.53%
ROCE 31.28%
ROIC 17.63%
ROICexc 32.75%
ROICexgc 35.01%
OM 41.83%
PM (TTM) 13.4%
GM 49.3%
FCFM 27.12%
ROA(3y)18.05%
ROA(5y)13.4%
ROE(3y)28.54%
ROE(5y)27.26%
ROIC(3y)25.97%
ROIC(5y)29.21%
ROICexc(3y)33.15%
ROICexc(5y)39.25%
ROICexgc(3y)39.5%
ROICexgc(5y)46.11%
ROCE(3y)47.13%
ROCE(5y)55.34%
ROICexcg growth 3Y-21.92%
ROICexcg growth 5Y-46.42%
ROICexc growth 3Y-20.01%
ROICexc growth 5Y-37.94%
OM growth 3Y-9.51%
OM growth 5Y-1.13%
PM growth 3Y12.45%
PM growth 5YN/A
GM growth 3Y-10.4%
GM growth 5Y-5.31%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 67.35%
Cap/Sales 7.76%
Interest Coverage 224.83
Cash Conversion 65.38%
Profit Quality 202.47%
Current Ratio 3.97
Quick Ratio 3.53
Altman-Z 3.69
F-Score5
WACC8.65%
ROIC/WACC2.04
Cap/Depr(3y)235.93%
Cap/Depr(5y)264.03%
Cap/Sales(3y)18.03%
Cap/Sales(5y)16.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.12%
EPS 3Y38.6%
EPS 5YN/A
EPS Q2Q%-88.74%
EPS Next Y-25%
EPS Next 2Y-41.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-49.41%
Revenue growth 3Y24.31%
Revenue growth 5Y14.76%
Sales Q2Q%-68.56%
Revenue Next Year-15.06%
Revenue Next 2Y-20.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.3%
EBIT growth 3Y12.49%
EBIT growth 5Y13.46%
EBIT Next Year-7.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y385.71%
FCF growth 3YN/A
FCF growth 5Y9.26%
OCF growth 1Y22.93%
OCF growth 3Y50.47%
OCF growth 5Y7.36%